Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brock T Shireman

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|March 5, 2004
Direct catalytic asymmetric aldol additions of methyl ynones. Spontaneous reversal in the sense of enantioinductionBarry M Trost, Alec Fettes, Brock T Shireman
Bioorganic & Medicinal Chemistry Letters|July 30, 2013
Selective orexin receptor antagonistsTerry P Lebold, Pascal Bonaventure, Brock T Shireman
Frontiers in Neuroscience|March 5, 2014
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonismChristine Dugovic, Jonathan E Shelton, Sujin Yun, et al.
Journal of the American Chemical Society|March 18, 2005
Dinuclear asymmetric Zn aldol additions: formal asymmetric synthesis of fostriecinBarry M Trost, Mathias U Frederiksen, Julien P N Papillon, et al.
Frontiers in Neuroscience|June 7, 2014
Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortexLeah Aluisio, Ian Fraser, Tamara Berdyyeva, et al.
Frontiers in Behavioral Neuroscience|May 24, 2017
Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in MiceSujin Yun, Michelle Wennerholm, Jonathan E Shelton, et al.
Nature|February 18, 2020
Copper-mediated synthesis of drug-like bicyclopentanesXiaheng Zhang, Russell T Smith, Chip Le, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonistsBrock T Shireman, Curt A Dvorak, Dale A Rudolph, et al.
ACS Chemical Neuroscience|January 13, 2016
Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 AntagonistsJeannie Ziff, Dale A Rudolph, Brice Stenne, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2015
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effectsPascal Bonaventure, Sujin Yun, Philip L Johnson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|March 5, 2004
Direct catalytic asymmetric aldol additions of methyl ynones. Spontaneous reversal in the sense of enantioinductionBarry M Trost, Alec Fettes, Brock T Shireman
Bioorganic & Medicinal Chemistry Letters|July 30, 2013
Selective orexin receptor antagonistsTerry P Lebold, Pascal Bonaventure, Brock T Shireman
Frontiers in Neuroscience|March 5, 2014
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonismChristine Dugovic, Jonathan E Shelton, Sujin Yun, et al.
Journal of the American Chemical Society|March 18, 2005
Dinuclear asymmetric Zn aldol additions: formal asymmetric synthesis of fostriecinBarry M Trost, Mathias U Frederiksen, Julien P N Papillon, et al.
Frontiers in Neuroscience|June 7, 2014
Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortexLeah Aluisio, Ian Fraser, Tamara Berdyyeva, et al.
Frontiers in Behavioral Neuroscience|May 24, 2017
Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in MiceSujin Yun, Michelle Wennerholm, Jonathan E Shelton, et al.
Nature|February 18, 2020
Copper-mediated synthesis of drug-like bicyclopentanesXiaheng Zhang, Russell T Smith, Chip Le, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonistsBrock T Shireman, Curt A Dvorak, Dale A Rudolph, et al.
ACS Chemical Neuroscience|January 13, 2016
Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 AntagonistsJeannie Ziff, Dale A Rudolph, Brice Stenne, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2015
A selective orexin-1 receptor antagonist attenuates stress-induced hyperarousal without hypnotic effectsPascal Bonaventure, Sujin Yun, Philip L Johnson, et al.
Pageof 2